4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?
Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether 4-PBA will increase the level of AAT in
persons with AAT deficiency whether or not they have liver disease.
Phase:
Phase 2
Details
Lead Sponsor:
University of Florida
Collaborators:
Alpha-1 Foundation Brantly, Mark L., M.D.
Treatments:
Alpha 1-Antitrypsin Butyric Acid Protein C Inhibitor